First News

Vascular Closure Devices Market Report Overview The large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices. The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent. The benefits of interventional cardiology procedures including reduced scarring and less pain due to their minimally invasive nature are driving the interventional cardiology market from vascular closure devices. Interventional cardiologists use vascular closure devices to close the artery after the procedure. Interventional cardiology deals ...

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. The global  vascular closure devices market  is expected to reach  USD 984.6 Million by 2022 from USD 704.8 Million in 2017 , at a  CAGR of 6.9% . Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is another factor that leads to cost savings. Additionally, malfunctioning of devices, poor quality, and underperformance of devices are the primary causes of product recalls. Product failur...

The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.  The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, whic...

Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a  vascular closure device  is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. The report provides an overall understanding of the market. In this report, the market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segment s,  the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surge...

Large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices. The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.  Major Key Players of the Vascular Closure Device Market are: Terumo Corporation (Japan), Abbott (U.S.), Cardinal Health Inc. (U.S.), Cardiva Medical Inc. (U.S.), Morris Innovative, Inc. (U.S.), Medtronic plc (Ireland), Essential Medical, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), TZ Medical, Inc. (U.S.), and Vasorum Ltd. (Ireland). Get a Sample PDF Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=180101468 Major Types of Vascular Closure Devices Market covered are: Interventional Cardiology,  Interventional Radiology/Vascular Surgery Vascular Closure Devices Market, by Type Passiv...

Market include the large number of approvals for vascular closure devices, the high prevalence of cardiovascular diseases, high prevalance of obesity, and increasing focus of market players on large-bore vascular closure devices. The market is segmented on the basis of type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Among these type segment s,  the passive approximators segment is expected to account for the largest share of the vascular closure devices market in 2017. The access segment includes femoral access and radial access. The procedure segment includes interventional cardiology and interventional radiology/vascular surgery. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Vascular closure devices market  are relatively high-priced devices compared to manual compression devices. A combination of botto...

In 2017, passive approximators segment accounted for the largest share of ~ 67% of the global vascular closure device market. The passive approximators consist of a plug, sealant, or a gel that can be deployed at the arteriotomy site to passively close the femoral artery. The passive approximators segment is further divided into collagen plugs, sealant or gel-based devices, and compression assist devices. The large share of this market can be attributed to the large number of approvals for vascular closure devices and the high prevalence of cardiovascular disease and obesity. However, the high cost of vascular closure devices and the increasing popularity of interventional procedures using radial arteries are likely to limit market growth to a certain extent. The global  vascular closure device market  is expected to reach USD 984.6 million by 2022. The key factors propelling the growth of the the vascular closure devices market are the rising prevalence of cardiovascular dise...

The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%. The major drivers for the market include many approvals for vascular closure devices, increasing focus of market players on large-bore vascular closure devices, the high prevalence of cardiovascular diseases, and high prevalence of obesity. On the other hand, the high cost of vascular closure devices, product recalls and failures, and increasing preference for interventional procedures using radial artery access are limiting the growth of the global market to a certain extent. In this report, the market has been segmented based on type, access, procedures, and geographies. The type segment includes passive approximators, active approximators, and external hemostasis devices. Passive approximators are expected to account for the largest share of the market in 2017. Passive approximators are the most widely used vascular closure devices i...